(Q34493092)

2 August 2017

1 reference

title

The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis (English)

1 reference

2 August 2017

1 reference

1 reference

Taillefer R

1

1 reference

2 August 2017

publication date

1 January 1999

1 reference

Seminars in Nuclear Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

29

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

16-40

1 reference

The positive predictive value of mammography

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Occult breast cancer: prevalence and radiographic detectability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Mammographic features of "early" breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Preoperative localization of clinically occult breast lesions: experience at a referral hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Delayed diagnosis of breast cancer as a result of normal mammograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

New methods for imaging the breast: techniques, findings, and potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Measurement of radioactive phosphorus in breast tumors in situ; a possible diagnostic procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Breast cancer imaging with mouse monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Diagnosis of Breast Carcinoma with Radiolabeled Monoclonal Antibodies (MoAbs) to Carcinoembryonic Antigen (CEA) and Human Milk Fat Globulin (HMFG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Somatostatin-receptor scintigraphy in primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

The synthesis of E-17 alpha-[131I]iodo-vinyl oestradiol and evaluation of its use as a radiotracer for oestrogen receptor positive breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Images of estrogen-receptor-positive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Breast scintigraphy with 99mTc-diethylene triamine penta-acetic acid for the detection of malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Breast cancer: PET imaging of estrogen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Clinical evaluation of tumor imaging with 201 TI chloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Breast carcinomas detected by thallium-201 scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Mechanism of 201Tl uptake in tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

201Tl scintigraphy in the staging of lung cancer, breast cancer and lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Evaluation of palpable breast masses with 201Tl scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Technetium-99m sestamibi: an indicator of breast cancer invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

The diagnostic value of planar and SPET scintimammography in different age groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Scintimammography in the diagnosis of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

99mTc-sestaMIBI breast scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Case report: technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile imaging of breast cancer and myocardial infarction in the same patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Tc-99m MIBI uptake in breast carcinoma and axillary lymph node metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Role of MIBI breast scintigraphy in evaluation of palpable breast lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Technetium-99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Axillary node metastasis detection in breast cancer with 99mTc-sestaMIBI and 111In-pentetreotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Breast cancer detection with Tc-99m tetrofosmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

99Tcm-tetrofosmin scintigraphy in the evaluation of palpable breast masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

99mTc-diphosphonate concentration in primary breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Radiopharmaceuticals for breast cancer imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Scintimammography (SMM) with 99mTc-MDP: an overview of the experience at the National Cancer Institute of Napoli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Tc-99m sestamibi uptake in infiltrating ductal carcinoma of the breast in a male patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Three patients with bilateral breast tumors examined by technetium-99m-sestamibi scintimammography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

Localization of an Occult Primary Breast Cancer with Technetium-99m Sestamibi Scan and an Intraoperative Gamma Probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2899%2980027-0

10.1016/S0001-2998(99)80027-0

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference